Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Spero Therapeutics is a biopharmaceutical company focused on developing novel treatments for rare and multi-drug resistant bacterial infections. Its pipeline includes oral and IV antibiotics targeting serious infections like cUTI, HABP/VABP, and NTM pulmonary disease. The company collaborates with partners like GSK and Meiji, leveraging proprietary technology and strategic licensing to address high unmet medical needs in infectious diseases.
This description was generated via AI from an annual report. Updated about 1 year ago.